Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV
Condition(s):HIV I Infection; Cardiovascular Risk Factor; Lipid Metabolism DisordersLast Updated:March 12, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):HIV I Infection; Cardiovascular Risk Factor; Lipid Metabolism DisordersLast Updated:March 12, 2024Recruiting
Condition(s):Pre-Exposure Prophylaxis of HIV-1 InfectionLast Updated:December 21, 2023Active, not recruiting
Condition(s):Healthy Adult ParticipantsLast Updated:March 5, 2024Recruiting
Condition(s):HIV PreventionLast Updated:January 5, 2024Recruiting
Condition(s):Hiv; Hormone TherapyLast Updated:May 6, 2023Active, not recruiting
Condition(s):Healthy VolunteersLast Updated:January 25, 2021Completed
Condition(s):Human Immunodeficiency VirusLast Updated:October 27, 2022Completed
Condition(s):HIV-1-infectionLast Updated:July 6, 2022Completed
Condition(s):HIV-1-infectionLast Updated:April 28, 2022Completed
Condition(s):HIVLast Updated:February 8, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.